NVST vs ONC
Envista Holdings vs BeOne Medicines AG — AI-powered side-by-side comparison
NVST
Envista Holdings
76
Strong Buy
VS
ONC
BeOne Medicines AG
64
Buy
| Metric | NVST | ONC |
| AI Score |
76
|
64
|
| Price |
$28.51
|
$359.20
|
| P/E Ratio |
48.34×
|
29.70×
|
| ROE |
1.5%
|
6.6%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
55.5%
|
87.8%
|
| Debt / Equity |
0.52×
|
0.22×
|
| Dividend Yield |
0.0%
|
0.0%
|
| RSI (14) |
59.3
|
84.1
|
| Beta |
0.861
|
0.5
|
| Expected Upside |
+1.4%
|
—
|
AI Committee View
Current Innellis committee reasoning for NVST versus ONC.
NVST leads by 12 points.
NVST scores 76/100 (Strong Buy) versus ONC at 64/100 (Buy).
NVST Committee View
100% agreement
4 analysts
The primary driver is 5 consecutive earnings beats -- consistent execution. The main limiting factor is 2 existing position pair(s) are highly correlated already. The committee is constructive but not yet at full conviction.
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
Bear Case
- Weekly trend is bearish while daily is bullish — against the higher-timeframe trend.
- Risk/reward is unfavorable: 14.2% downside vs 1.4% upside.
ONC Committee View
50% agreement
6 analysts
The committee is genuinely divided. Growth Analyst sees a compelling case — revenue growing 36.2% yoy -- genuine top-line momentum. Value Analyst remains cautious — p/e of 86.0 is expensive by classic value standards. This disagreement is itself the signal — the setup is not clean in either direction.
Bull Case
- Revenue growing 36.2% YoY -- genuine top-line momentum — Growth
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- P/E of 86.0 is expensive by classic value standards — Value
- Price-to-book of 8.7x prices in significant intangible value — Value
- RSI at 84 is in overbought territory — Technical